Science

Immune-mediated liver injury by Immune checkpoint inhibitors

Evangelos Triantafyllou, Cathrin L. C. Gudd and Lucia A. Possamai

Dec 16, 2024, 12:23

Immune-mediated liver injury by Immune checkpoint inhibitors

Erman Akkus, Medical Oncology fellow at Ankara University, shared a recent article by Evangelos Triantafyllou on X:

“Immune-mediated liver injury by Immune checkpoint inhibitor (ICIs) in Nature Reviews Gastroenterology and Hepatology.

From mechanisms to treatment.”

Title: Immune-mediated liver injury from checkpoint inhibitors: mechanisms, clinical characteristics and management

Authors: Evangelos Triantafyllou, Cathrin L. C. Gudd and Lucia A. Possamai

liver injury

Erman Akkus is a medical oncology fellow at the Ankara University, Faculty of Medicine. Previously, he was an Internal Medicine Resident at the Ankara University, Faculty of Medicine. He was also a Visiting Researcher at the University of Oslo. He completed his education from the Medical University of Vienna.

More posts featuring Erman Akkus.

cancer Cathrin L. C. Gudd Erman Akkus Evangelos Triantafyllou Gastroenterology Hepatology ICIs liver injury Lucia A. Possamai Nature Reviews OncoDaily Oncology

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Giuliana Rancic and Breast Cancer: How She Went Against, How She Survived, and More

Vincent Rajkumar: Paradigm changing AQUILA randomized trial in high risk smoldering myeloma

Special Coverage